Home » Glenmark in Licensing Deal With US Company for Cholesterol Drug
Glenmark in Licensing Deal With US Company for Cholesterol Drug
Drug firm Glenmark on Tuesday said it has signed an exclusive licensing agreement with the US-based Par Pharmaceutical to sell generic cholesterol-lowering
drug Ezetimibe in the US market.
The Economic Times
The Economic Times
Upcoming Events
-
07May
-
14May
-
30May